Erba Mannheim acquires Turkish IVD Co
ERBA Diagnostics Mannheim, GmbH (Erba), a 100 percent subsidiary of Transasia Bio-Medicals Ltd, (Transasia) – India
×
News
Stem cell therapy found for leukaemia
In a ray of hope for millions of leukaemia patients, American scientists have claimed to have developed a technique which multiplies the small number of stem cells in the donor blood, making it much more potent for the treatment of the fatal disease.
First Genetic Test for IVF Success
Scientists have developed the first genetic blood test for predicting the chances that in vitro fertilization (IVF) will lead to a successful pregnancy.
Abdominal Aortic Stent Graft Market to Reach $300m
A report by the Millennium Research Group says that the abdominal aortic stent graft market in Europe is estimated to reach $300m by 2015.
Action Plan to Halt Malaria Drug Resistance
The United Nations health agency launched a new action plan to halt the spread of resistance to artemisinin, the world’s most potent treatment for malaria, warning that the tremendous gains made in recent years against the disease are under threat.
Devices to Optimise Diabetes Management
As Noval methods of blood glucose monitoring and uation have enabled treatment adjustments that would not have been made on the basis of intermittent finger prick readings, thus dramatically improving the quality of the lives of millions of diabetics around the world.
Cardiac Life-Support Pump Trial Successful
Zoll Medical Corporation has successfully completed a trial uating Auto Pulse, its non-invasive cardiac life-support pump.
European CE Mark Approval for Obesity Device
IntraPace has received European CE mark approval for its abiliti system as a treatment for obesity.
Diabetes Charity and Medical Device Company to Develop ‘Artificial Pancreas’
The Juvenile Diabetes Research Foundation will team up with Animas Corporation, a subsidiary of Johnson and Johnson, to create an “artificial pancreas,” the diabetes charity has announced.
Severe Heart Attacks Better Detected with New Device
A new device can detect severe heart attacks in more patients, leading to better diagnoses and faster treatment, according to new research. The new 80-lead electrocardiogram (ECG/EKG), PRIME ECG, can give physicians a broader reading of the heart muscle than the traditional 12-lead ECG.
Devices to Fight Obesity to Launch in 2011
Three new fat removal technologies that are awaiting approval from the US Food and Drug Administration should be available to patients by 2011.
Automated Method to Track E.Coli
Researchers from Purdue University Calumet have turned to a simple, automated method of tracking E.coli.
Protein behind Rheumatoid Arthritis Found
Researchers at Imperial College London have discovered a protein that triggers rheumatoid arthritis.
